In vitro, MDS-BM-MSCs display modifications in the expression of various cytokines, including reduced production of stem cell factor (SCF), granulocyte cell stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF), and augmented IL-6 production [156]. This evidence concerns the gene CSF2 and myelodysplastic syndrome.